The healthcare index jumped 1.8 per cent after the country approved Celltrion's experimental Covid-19 treatment for Phase 2/3 clinical trials.
The won ended at 1,160.3 per US dollar on the onshore settlement platform, up 1.22 per cent, the sharpest gain since late-March.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessTimes - 🏆 15. / 51 Read more »